CA2500521A1 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides Download PDF

Info

Publication number
CA2500521A1
CA2500521A1 CA002500521A CA2500521A CA2500521A1 CA 2500521 A1 CA2500521 A1 CA 2500521A1 CA 002500521 A CA002500521 A CA 002500521A CA 2500521 A CA2500521 A CA 2500521A CA 2500521 A1 CA2500521 A1 CA 2500521A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
protein
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002500521A
Other languages
English (en)
Inventor
Y. Tom Tang
Vinod Asundi
Feiyan Ren
Jie Zhang
Tom Wehrman
Zhiwei Wang
Yunqing Ma
Dunrui Wang
Rui-Hong Chen
Qing A. Zhao
Jian-Rui Wang
Malabika Ghosh
Aidong J. Xue
Gezhi Weng
Ping Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2500521A1 publication Critical patent/CA2500521A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Cette invention se rapporte à de nouveaux acides nucléiques, à de nouvelles séquences de polypeptides codées par ces acides nucléiques et à l'utilisation de ceux-ci.
CA002500521A 2002-10-02 2003-09-30 Nouveaux acides nucleiques et polypeptides Abandoned CA2500521A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/416,186 2002-10-02
US41618602P 2002-10-22 2002-10-22
PCT/US2003/030720 WO2004080148A2 (fr) 2002-10-02 2003-09-30 Nouveaux acides nucleiques et polypeptides

Publications (1)

Publication Number Publication Date
CA2500521A1 true CA2500521A1 (fr) 2004-09-23

Family

ID=32990311

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002500521A Abandoned CA2500521A1 (fr) 2002-10-02 2003-09-30 Nouveaux acides nucleiques et polypeptides

Country Status (5)

Country Link
EP (1) EP1556490A4 (fr)
JP (1) JP2006517094A (fr)
AU (1) AU2003303305A1 (fr)
CA (1) CA2500521A1 (fr)
WO (1) WO2004080148A2 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209884D0 (en) 2002-04-30 2002-06-05 Ares Trading Sa Proteins
EP2311468B1 (fr) * 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gène surexprimé dans le cancer
US20070037204A1 (en) * 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
US7534562B2 (en) 2003-09-30 2009-05-19 Daiichi Pharmaceutical Co., Ltd. Tetrahydrofolate synthetase gene
PL2157192T3 (pl) 2003-10-10 2014-01-31 Deutsches Krebsforsch Kompozycje do diagnozowania i terapii chorób związanych z nieprawidłową ekspresją futrin (R-spondin)
CN1902494B (zh) * 2003-11-03 2010-10-27 伊西康公司 用于检测广谱细菌的方法、肽和生物传感器
GB0326393D0 (en) 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
JPWO2005070964A1 (ja) * 2004-01-27 2008-01-17 株式会社医学生物学研究所 単球の単離方法
US20100031378A1 (en) 2008-08-04 2010-02-04 Edwards Joel A Novel gene disruptions, compositions and methods relating thereto
WO2005079566A2 (fr) * 2004-02-12 2005-09-01 Lexicon Genetics Incorporated Nouvelles disruptions geniques, compositions et procedes associes
PL2031063T3 (pl) * 2004-06-18 2014-04-30 Univ Duke Modulatory receptorów węchowych
EP2479277B1 (fr) 2004-07-22 2015-09-02 Five Prime Therapeutics, Inc. L'utilisation de MGD-CSF dans le traitement de maladie d'Alzheimer
US20090087474A1 (en) * 2005-01-07 2009-04-02 Petersen Thomas N Therapeutic use of growth factors,nsg29 and nsg31
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
WO2008046649A1 (fr) 2006-10-20 2008-04-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Utilisation de rspondins en tant que modulateurs de l'angiogenèse et de la vasculogenèse
AU2008222580A1 (en) * 2007-03-07 2008-09-12 The Council Of The Queensland Institute Of Medical Research Novel human ssDNA binding proteins and methods of cancer diagnosis
PT2186889E (pt) 2007-08-20 2015-06-17 Oncotherapy Science Inc Péptido cdca1 e agente farmacêutico que o compreende
CN102099055A (zh) 2007-10-04 2011-06-15 津莫吉尼蒂克斯公司 B7家族成员zB7H6及相关的组合物和方法
JP5547637B2 (ja) * 2007-10-05 2014-07-16 インデックス・ファーマシューティカルズ・アクチエボラーグ 浮腫を治療または軽減するための新規な化合物およびその使用方法
PT3106874T (pt) * 2007-10-25 2020-05-08 Toray Industries Método para a deteção de cancro
JP5572938B2 (ja) * 2007-10-25 2014-08-20 東レ株式会社 免疫誘導剤
ES2660414T3 (es) * 2007-10-25 2018-03-22 Toray Industries, Inc. Inductor de la respuesta inmunitaria
US8198406B2 (en) * 2007-11-07 2012-06-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
WO2009086106A1 (fr) * 2007-12-21 2009-07-09 Mount Sinai School Of Medicine Of New York University Utilisation de protéine de podocan dans le traitement de maladies cardiovasculaires
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
EP2872532A4 (fr) 2012-07-10 2016-04-13 Oncotherapy Science Inc Peptides épitopes du cdca1 pour cellules th1 et vaccins les contenant
CN105188749B (zh) 2012-12-21 2017-12-19 西雅图基因公司 抗ntb‑a抗体及相关组合物和方法
US20180305451A1 (en) * 2015-07-13 2018-10-25 Compugen Ltd. Hide1 compositions and methods
GB201520568D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
CN106047818A (zh) * 2016-08-05 2016-10-26 武汉赛云博生物科技有限公司 癌胚抗原特异性tcr基因修饰的t细胞及其抑癌用途
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
WO2020117715A1 (fr) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Analogues d'oligo-benzamide et leur utilisation dans le traitement du cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009474A1 (en) * 2000-05-24 2004-01-15 Leach Martin D. Novel human polynucleotides and polypeptides encoded thereby

Also Published As

Publication number Publication date
AU2003303305A1 (en) 2004-09-30
WO2004080148A3 (fr) 2005-03-31
EP1556490A2 (fr) 2005-07-27
JP2006517094A (ja) 2006-07-20
WO2004080148A2 (fr) 2004-09-23
EP1556490A4 (fr) 2006-04-05

Similar Documents

Publication Publication Date Title
US6743619B1 (en) Nucleic acids and polypeptides
US6610536B2 (en) Nucleic acids and polypeptides
CA2500521A1 (fr) Nouveaux acides nucleiques et polypeptides
CA2440257A1 (fr) Nouveaux acides nucleiques et polypeptides
WO2001064835A2 (fr) Nouveaux acides nucleiques et polypeptides
EP1325120A2 (fr) Acides nucleiques et polypeptides
WO2001088088A2 (fr) Nouveaux acides nucleiques et polypeptides
CA2461280A1 (fr) Nouveaux acides nucleiques et polypeptides
US20040053245A1 (en) Novel nucleic acids and polypeptides
WO2002074961A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
AU2734401A (en) Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
CA2401505A1 (fr) Nouveaux acides nucleiques et polypeptides
US20020150898A1 (en) Novel nucleic acids and polypeptides
WO2004087874A2 (fr) Acides nucleiques et polypeptides
WO2002018424A9 (fr) Nouveaux acides nucleiques et polypeptides
WO2002044340A2 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053453A2 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO2002077180A2 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
US20050170374A1 (en) Novel nucleic acids and polypeptides
CA2409164A1 (fr) Nouveaux acides nucleiques et polypeptides
CA2406121A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
WO2001057261A9 (fr) Procedes et matieres lies a des polypeptides et des polynucleotides du type proteine repetee riche en leucine (du type proteine lrr)
WO2001057187A2 (fr) Nouveaux acides nucleiques et polypeptides medullaires
WO2001064840A2 (fr) Nouveaux acides nucleiques et polypeptides de moelle osseuse
CA2453344A1 (fr) Nouveaux acides nucleiques et nouveaux polypeptides

Legal Events

Date Code Title Description
FZDE Discontinued